Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Disclosure of research results in genetic studies of Parkinson's disease caused by LRRK2 mutations.

Movement disorders : official journal of the Movement Disorder Society - 1 Jun 2015

Pont-Sunyer Claustre, Bressman Susan, Raymond Deborah, Glickman Amanda, Tolosa Eduardo, Saunders-Pullman Rachel

Abstract excerpt

With the advent of large genetic studies examining both symptomatic and asymptomatic individuals, whether and how to disclose genetic research results have become pressing questions. The need is particularly acute in the case of LRRK2 research: Movement centers worldwide are recruiting cohorts of individuals with Parkinson's disease (PD) and their family members, including asymptomatic carriers. Clinical features...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Research
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2

Share to Mutation

Share to Parkinson Disease

Share to Protein Serine-Threonine Kinases

Share to Truth Disclosure

Source

Open in PubMed Open full text

Identifiers

PMID: 25952684
DOI: 10.1002/mds.26250
PMCID: PMC4478096

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Disclosure of research results in genetic studies of Parkinson's disease caused by LRRK2 mutations.PMID 25952684Read ↗

Global Perspectives on Returning Genetic Research Results in Parkinson’s DiseaseSemantic proximity Read ↗

More Than Results: A Qualitative Study on the Role of Person-Centered Genetic Counseling in Parkinson’s Disease ResearchSemantic proximity Read ↗

A Closer Look at the Recommended Criteria for Disclosing Genetic Results: Perspectives of Medical Genetic Specialists, Genomic Researchers, and Institutional Review Board ChairsSemantic proximity Read ↗

Ethical, Legal and Social Implications of Susceptibility Genetic Testing for Late-Onset Neurodegenerative DiseasesSemantic proximity Read ↗

Perspectives of People At-Risk on Parkinson's Prevention ResearchSemantic proximity Read ↗

Disclosing incidental findings in genetics contexts: a review of the empirical ethical research.Semantic proximity Read ↗

Genetic testing for neurodegenerative diseases: Ethical and health communication challenges.Semantic proximity Read ↗

Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues.Semantic proximity Read ↗

Perspectives of People At-Risk on Parkinson's Prevention Research.Semantic proximity Read ↗

Disclosing individual genetic research results to deceased participants' relatives by means of a qualified disclosure policy.Semantic proximity Read ↗

Ethical signposts for clinical geneticists in secondary variant and incidental finding disclosure discussions.Semantic proximity Read ↗

Reflecting on Earlier Experiences with Unsolicited Findings: Points to Consider for Next‐Generation Sequencing and Informed Consent in DiagnosticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.